**Specification Table**Subject Area:*Chemistry*More specific subject area:*Analytical Chemistry*Method name:*Liquid-phase microextraction based on the solidification of deep eutectic solvent (LPME-SDES)*Name and reference of original method:*Paiva (2014):* \[[@bib0015]\]Resource availability:*Not applicable*

Method details {#se0155}
==============

In recent years, a plethora of extraction techniques has emerged as environmental-friendly alternatives to conventional extraction procedures. Deep eutectic solvents (DESs), as a subclass of Ionic liquids, show comparable characteristics; they are cheaper and easy to be produced due to lower cost of the raw materials, less toxic and often biodegradable \[[@bib0005],[@bib0010]\]. DESs usually provide a network of hydrogen bond acceptor (HBA) and hydrogen bond donor (HBD), thus favoring the dissolution process of target analytes \[[@bib0015]\]. DESs consist of two or three components with a melting point lower than their individual components, including HBD such as urea, glycerol, carboxylic acid, sugar, and the HBA such as quaternary ammonium salt (Choline Chloride) in a particular molar ratio \[[@bib0020]\]. DESs not only have the advantages of low volatility, low vapor pressure, high thermal stability and high ability to extract organic and inorganic compounds, but also have low cost and easy preparation of non-toxic compounds. However, DESs consist of Choline Chloride (ChCI), urea, glycerol, carboxylic acid or sugars, which have a high hydrophobicity, which affects their use in different matrices \[[@bib0025],[@bib0030]\].

Chemicals and materials {#sec0005}
=======================

Sodium selenite and sodium selenate (both purchased from Merck, Darmstadt, Germany) were used for preparation of stock standard solutions of selenite and selenate with a concentration of 1000 mg l^−1^. Stock standard solutions of As(III) and As(V) with a concentration of 1000 mg l^−1^ were obtained by dissolving appropriate amounts of As~2~O~3~ and Na~2~HAsO~4~ (Merck, Darmstadt, Germany). An Hg (II) standard stock solution (1000 mg l^−1^ in 1% nitric acid, 250 ml) was purchased from Fluka, Buchs, Switzerland. The CH~3~Hg^+^ 1000 mg l^−1^ stock solution was prepared by dissolving appropriate amount of its chloride (Merck, Darmstadt, Germany) in the smallest possible volume of methanol and diluting to volume with deionized water. The stock standard solutions were diluted to prepared a required standard solutions with 0.1 M HCl. The analytical grade diethyldithiophosphoric acid (DDTP) as chelating agent was obtained from Merk (Darmstadt, Germany). Iridium solution with concentration of 1000 mg l^−1^ in hydrogen chloride (Sigma-Aldrich, St. Louis, Missouri, USA) was used as the chemical modifier. Decanoic acid and choline chloride were purchased from Sigma-Aldrich (St. Louis, Missouri, USA).

Instrumentation {#sec0010}
===============

An Analytik Jena AG Model nov AA 400 (Jena, Germany) atomic absorption spectrometer equipped with a deuterium background correction system, a transversely heated graphite tube atomizer and a MPE60 auto-sampler were employed throughout measurements. Pyrolytic graphite coated tubes with PIN-graphite platform (Analytik Jena, Part No.:407-A81.026, Jena, Germany) were applied for the optimizations with aqueous standards. A hollow cathode lamp was used as the radiation source. Argon 99.999% was used as purge and protective gas. Integrated absorbance (peak area) was used exclusively for signal evaluation. The sample injection volume was 20 μl in all experiments. The instrumental parameters and temperature program for the graphite atomizer are listed in [Table 1](#tbl0005){ref-type="table"}. The pH values were measured by Metrohm pH meter Model 692 (Herisau, Switzerland). A Multi-Wave 3000 microwave-assisted UV system (MUV, Anton Paar, Graz, Austria) was used for converting R-Hg to Hg^2+^.Table 1Instrumental analytical conditions of investigated metal ions.Table 1HgSeAsSpectrometer parameters253.7196.0193.7Wavelength (nm)0.20.70.8Slit width (nm)585Lamp current (mA)Gas flow (ml min^−1^)Time (s)Temperature (°C)StepHoldRampHgSeAs60021505050Pre-warming600155808080Inject modifierInject sample60015109590110Drying I600205110100240Drying II60010102101000850Ashing0102101000850Gas stop step030110020002100Atomization120020150022002400Cleaning

Sampling and sample preparation {#sec0015}
===============================

Blood samples were collected from five children (3 girls and 2 boys) who were patient under treatment, kindly provided by the Clinic of Mohammad Kermanshahi Hospital (Kernanshah, Iran). The age was in the range 2--10 years. To preparation of sample, 1.0 ml of blood sample was placed in a 10-ml glass tube and 600 μl acetonitrile and 900 μl of 15% (w/v) ZnSO~4~ was added. The glass tube was vortexed for 5 min, maintained at 5 °C for 10 min followed by centrifugation at 5000 rpm for 3 min. Then, the supernatant was collected in another tube and this solution was diluted to 10.0 ml using ultrapure water. The resulting solution was then subjected to the LPME--SDES procedure.

LPME-SDES procedure {#sec0020}
===================

An aliquot of 10.0 ml of ultra-pure water or pretreated/diluted blood sample spiked or not with target analytes was placed in a 10-ml test tube and 60 μl of DES (extraction solvent) containing 15.0 μL DDTP (chelating agent) was rapidly injected into the sample solution with a 100-μL syringe (Gastight, Hamilton, Reno, NV, USA). The mixture was then shaken using a vortex agitator for 5 min to ensure full contact of the DES and target ions inside the sample solution. The mixture was then centrifuged for 4 min at 5000 rpm in order to separate the mixture into phases. After centrifugation, the fine droplets of DES float at the top of the test tube. The test tube was then transferred into an ice bath and the DES was solidified after few minutes. Then obtained solidified DES was transferred into a conical vial where it was melted immediately. To decrease viscosity and simply injected into the GFAAS, a 20 μl acidic ethanol added into the vial. Finally, for quantitation of target ions, 30.0 μl of the extract using an auto-sampler was injected into the GFAAS and was subjected to the temperature program, shown in [Table 1](#tbl0005){ref-type="table"}.

Method validation {#sec0025}
=================

The analytical characteristics of the method, i.e., precision, detection limits and linearity, were investigated under the chosen experimental conditions. The results are listed in [Table 2](#tbl0010){ref-type="table"}. The percent relative standard deviations (RSDs %) were between 2.2 and 4.1. The limit of detection, defined as C~L~ = 3S~B~/m (where C~L~, S~B~, and m are the limit of detection, standard deviation of the blank and slope of the calibration graph, respectively), were obtained between 0.015 and 0.10 μg l^−1^ for different metal ions. Linear ranges (LRs) of 0.15--40 μg l^−1^ for As, 0.05--5.0 μg l^−1^ for se and 0.30--60 μg l^−1^ for Hg were obtained. The correlation coefficient of the calibration curves were in the range of 0.993--0.999. The enhancement factor, obtained from the slope ratio of calibration graph after and before extraction, were in the range of 98--106.Table 2Figures of merit of the proposed method.Table 2AnalyteEnhancement factorDetection limit (μg l^−1^)RSD% (intra--day, n = 7)RSD% (inter--day, n = 7)Linear range (μg l^−1^)r^2^As1060.053.24.70.15--400.995Se990.0152.23.50.05--5.00.999Hg980.104.15.80.30--600.993

Determination of As in blood samples {#sec0030}
====================================

After applying the proposed methodology, total inorganic arsenic (iAs) was then measured after the reduction of As(V) to As(III) with sodium thiosulfate and potassium iodide. As(V) was calculated by the difference between the total As and As(III). As(III) and As(V) in all blood samples were detected at different concentration levels and they were confirmed by spiking As(III) and As(V) into the all samples. The concentration of As(III) and As(V) in the blood samples are shown in [Table 3](#tbl0015){ref-type="table"}. Blood samples were spiked with As(III) and As(V) standards to assess matrix effects. The relative recoveries of As(III) and As(V) from blood samples at spiking different levels are listed in [Table 3](#tbl0015){ref-type="table"}. In addition, the accuracy of the proposed method was evaluated by analyzing a standard reference material (SRM) NIST-2669 Inorganic Arsenic Species in Frozen Human Urine from National Institute of Standards and Technology (NIST), with certified As(III) and As(V) content of 1.47 ± 0.10 μg l^--1^ and 2.41 ± 0.30 μg l^--1^, respectively. No significant difference was found between the result obtained by employing the proposed method and the certified value ([Table 3](#tbl0015){ref-type="table"}).Table 3Determination of As(III) and As(V) in blood samples, and relative recovery of spiked arsenic in these samples[a](#tblfn0005){ref-type="table-fn"}.Table 3samplesAnalyteAdded (μg l^−1^)Found, mean ± SD[b](#tblfn0010){ref-type="table-fn"} (n = 3) (μg l^−1^)Relative recovery (%)Blood 1 (taken from a 2-year-old girl)As(III)03.2 ± 0.16--58.3 ± 0.411021013.1 ± 0.899As(V)02.1 ± 0.14--57.3 ± 0.31021011.8 ± 0.797  Blood 2 (taken from a 5-year-old girl)As(III)00.83 ± 0.04--22.88 ± 0.1610344.65 ± 0.295As(V)01.20 ± 0.05--23.08 ± 0.159445.23 ± 0.3101Blood 3 (taken from a 6-year-old girl)As(III)07.12 ± 0.4--310.22 ± 0.6103613.04 ± 0.599As(V)04.33 ± 0.18--37.40 ± 0.4102610.12 ± 0.797  Blood 4 (taken from a 4-year-old boy)As(III)01.60 ± 0.04--56.52 ± 0.2981011.65 ± 0.6100As(V)02.4 ± 0.7--57.3 ± 0.4981012.2 ± 1.097  Blood 5 (taken from a 10-year-old boy)As(III)05.62 ± 0.2--27.5 ± 0.49349.7 ± 0.3101As(V)01.5 ± 0.06--23.4 ± 0.19545.7 ± 0.3107  NIST SRM-2669As(III)1.47 ± 0.10[c](#tblfn0015){ref-type="table-fn"}1.43 ± 0.0897As(V)2.41 ± 0.30[c](#tblfn0015){ref-type="table-fn"}2.44 ± 0.22101[^1][^2][^3]

Determination of Se in blood samples {#sec0035}
====================================

Determination of total inorganic selenium is based on the conversion of Se(VI) species into Se(IV), which are then analyzed by GFAAS. Gentle boiling in 5 mol l^−1^ HCl medium for one hour and adjusting pH to 3 were used as the appropriate conditions for rapid reduction of Se(VI) to Se(IV). Finally, the concentration of Se(VI) was calculated by subtracting the Se(IV) concentration from the total inorganic selenium concentration. Results in [Table 4](#tbl0020){ref-type="table"} show that all samples contain selenite and selenate with different concentrations. To validate the method and evaluate the effects of the matrix, all samples were spiked with standard selenite and selenate solutions. Relative recovery of selenite and selenate in spiked blood samples at various concentration levels is shown in [Table 4](#tbl0020){ref-type="table"}, ranging from 91 to 105%. Moreover, the accuracy of the LPME-SDES was appraised by analyzing a standard reference material (SRM) NIST-1598A inorganic constituent in frozen animal (Bovine and Porcine) serum, with certified Se content of 134.4 ± 5.8 μg l^--1^. No remarkable difference was observed between the result gained by applying the presented method and the certified value ([Table 4](#tbl0020){ref-type="table"}).Table 4Determination of Se(IV) and Se(VI) in blood samples, and relative recovery of spiked Se in these samples.Table 4SamplesAnalyteAdded (μg l^−1^)Found, mean ± SD (n = 3) (μg l^−1^)Relative recovery (%)Blood 1 (taken from a 2-year-old girl)Se(IV)022.5 ± 1.6--1538.1 ± 3.1104Se(VI)09.7 ± 0.4--1525.4 ± 2.3105  Blood 1 (taken from a 5-year-old girl)Se(IV)021.2 ± 1.7--2039.8 ± 3.393Se(VI)011.4 ± 0.6--2031.5 ± 2.4101  Blood 1 (taken from a 6-year-old girl)Se(IV)028.0 ± 1.5--2348.5 ± 3.5103Se(VI)016.2 ± 0.8--2337.4 ± 2.292  Blood 4 (taken from a 4-year-old boy)Se(IV)040.6 ± 2.9--2563.3 ± 4.491Se(VI)023.5 ± 1.6--2547.4 ± 3.296  Blood 4 (taken from a 10-year-old boy)Se(IV)047.3 ± 2.4--3076.6 ± 5.398Se(VI)021.6 ± 1.3--3052.5 ± 4.1103(SRM) NIST-1598ATotal Se134.4 ± 5.8[a](#tblfn0020){ref-type="table-fn"}131.3 ± 6.598[^4]

Determination of Hg in blood samples {#sec0040}
====================================

Determination of total mercury (t-Hg) is based on the conversion of organic mercury(R-Hg) species into Hg^2+^, which are then analyzed by GFAAS. Ultraviolet (UV) light and microwave were used as the appropriate sources for rapid conversion of R-Hg to Hg^2+^. In this work, we used MUV 3000, a closed vessel microwave assisted-UV system, equipped with both the thermal and radiant (UV) energies. Total Hg was obtained when the aqueous samples containing both Hg^2+^ and R-Hg was put on vessel in special conditions (180 °C, UV) for 15 min. All R-Hg species were converted to Hg^2+^. Finally, the concentration of R-Hg was calculated by subtracting the Hg^2+^ concentration from the t-Hg concentration. Mercury in all blood samples were detected at different concentration levels ([Table 5](#tbl0025){ref-type="table"}). Blood samples were spiked with Hg^2+^ standard solution to assess matrix effects. The results of relative recovery and the concentrations obtained in spiked studies of the blood samples are also included in [Table 5](#tbl0025){ref-type="table"}. In addition, the accuracy of the proposed methodology was evaluated by analyzing a standard reference material (SRM) NIST-955C Toxic Metals in Frozen Caprine Blood, with certified contents of 9.0 ± 1.3 and 17.8 ± 1.6 μg l^--1^ inorganic mercury and total mercury, respectively. No significant difference was found between the results obtained by employing the proposed method and the certified value. The determined value of 8.6 ± 1.4 μg l^--1^ for inorganic mercury and 18.2 ± 1.5 μg l^--1^ for total mercury are in satisfactory agreement with the certified values.Table 5Determination of Hg^2+^, R-Hg and t-Hg in blood samples and relative recovery of spiked mercury in these samples.Table 5samplest-Hg (μg l^−1^)Analyte speciationAdded (μg l^−1^)Found, mean ± SD (n = 3) (μg l^−1^)Relative recovery (%)Blood 1 (taken from a 2-year-old girl)2.02Hg^2+^00.82 ± 0.13--22.90 ± 0.2110433.61 ± 0.2593R-Hg01.20 ± 0.05--23.31 ± 0.2610534.10 ± 0.2297  Blood 1 (taken from a 5-year-old girl)1.40Hg^2+^00.44 ± 0.05--33.23 ± 0.179344.51 ± 0.32102R-Hg00.96 ± 0.07--34.15 ± 0.2510644.74 ± 0.2694  Blood 1 (taken from a 6-year-old girl)3.35Hg^2+^02.03 ± 0.15--13.12 ± 0.2010923.90 ± 0.3093R-Hg01.32 ± 0.10--12.40 ± 0.1610823.22 ± 0.2295  Blood 1 (taken from a 4-year-old boy)2.06Hg^2+^00.56 ± 0.04--22.35 ± 0.109033.63 ± 0.15102R-Hg01.50 ± 0.12--23.30 ± 0.409034.71 ± 0.25107  Blood 1 (taken from a 10-year-old boy)3.65Hg^2+^01.10 ± 0.13--45.00 ± 0.289756.22 ± 0.33102R-Hg02.55 ± 0.24--46.39 ± 0.509657.61 ± 0.46101
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[^1]: These data are based on the diluted volumes of blood samples and dilution effect was considered for calculation of them.

[^2]: Standard deviation.

[^3]: Certified values.

[^4]: Certified value.
